glp-1/gip agonist Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements Understand GLP-1/GIP Dual Agonist Tirzepatide

In plain English, these drugs slow your digestive system, stretching out the satiety and fullness you get from eating a meal

These two forces work together to achieve controlled weight loss goals

Lancet Diabetes Endocrinol (2019) 7(10):77685

Likewise, first- and second-phase insulin secretion and insulin sensitivity were increased, while postprandial plasma glucose concentrations and plasma glucagon concentrations were lowered

At the time of the 2025 Super Bowl, there was a shortage of the branded GLP-1 drugs semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound, which opened the door for compounding pharmacies to sell non-identical versions under specific FDA regulations

Employer Benefits: Data on employer-provided coverage for GLP-1 agonists came from the KFF 2025 Employer Health Benefits Survey